Patent details
EP2540696 Title: Trans carotenoids, formulation and uses
Basic Information
- Publication number:
- EP2540696
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP121662936
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Trans carotenoids, formulation and uses
- French Title of Invention:
- Transcaroténoïdes, formulation les comprenant et leurs utilisations
- German Title of Invention:
- Trans-Karotinoide, deren Formulierung und Verwendung
- SPC Number:
Dates
- Filing date:
- 24/02/2006
- Grant date:
- 01/01/2020
- EP Publication Date:
- 02/01/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/01/2020
- EP B1 Publication Date:
- 01/01/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/02/2020
- Expiration date:
- 24/02/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/12/2019
- Name:
- Diffusion Pharmaceuticals LLC
- Address:
- 999 Grove Street, Suite 203, Charlottesville, VA 22902, United States (US)
Inventor
1
- Name:
- Lanz, Marc
- Address:
- Switzerland (CH)
2
- Name:
- Gainer, John, L.
- Address:
- United States (US)
Priority
- Priority Number:
- 655422 P
- Priority Date:
- 24/02/2005
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/11; A61K 31/202; A61P 35/00; C07C 57/03; C07C 57/13; C07C 69/602;
Publication
European Patent Bulletin
- Issue number:
- 202001
- Publication date:
- 01/01/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|